[177Lu]Ludotadipep

N/A

Report date: 2025/09/09 15:00:17

Base Information

Drug Name[177Lu]Ludotadipep

Drug Alias NameLutetium-177 labeled PSMA radio ligand therapy（Futurechem）Lu-177 Ludotadipep177Lu-FC705177Lu-FC-705

ClassificationRadiation-emitting products > Radioactive therapeutic agentRadiation-emitting products > Nuclides > Lutetium > 177LuRadiation-emitting products > Radionuclide Drug Conjugates

Mechanisms of ActionProstate-Specific Membrane Antigen inhibitorsIonising radiation emitters

TargetsProstate-Specific Membrane Antigen

Therapy Area/IndicationsProstatic Neoplasms, Castration-Resistant

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryUnited StatesSouth Korea

CombinationsNo

Global Highest StatusPhase 2 Clinical

Highest Status in ChinaN/A

Originator CompaniesFuturechem

China Registration ClassN/A

Develop Information

Active CompaniesFuturechem

Inactive CompaniesN/A

Active IndicationsProstatic Neoplasms, Castration-Resistant

Inactive IndicationsN/A

Other Information

ATC CodeN/A